Press Releases
2018
The Jenex Corporation Announces Board Change; Appointment of Advisory Board, Debt Settlement and Option Grants
2018-01-17 8:08 AM ET
Jenex's TherOZap(TM) Technology Indicates Effectiveness in Inhibiting Zika Virus After Pre-Clinical Study
2018-01-08 4:57 PM ET
2017
The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
2017-12-12 9:29 AM ET
The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum 2017-12-04 9:23 AM ET
The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
2017-11-23 8:46 AM ET
The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
2017-11-02 7:00 AM ET
The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)
The Jenex Corporation Announces Grant of Stock Options
2017-10-06 5:19 PM ET
The Jenex Corporation Terminates Exclusive License Agreement with Luminar Media Group Inc.
2017-10-02 4:33 PM ET
The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)
2017-09-19 7:00 AM ET
Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus
2017-09-14 4:30 PM ET
Jenex is Unaware of Any Material Change
2017-08-30 12:56 PM ET
2017-08-17 8:57 AM ET
2017-06-21 4:26 PM ET
The Jenex Corporation Announces Equity Financing with Insider Participation
2017-05-29 4:18 PM ET
Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network
2017-05-23 7:00 AM ET
2017-04-18 9:17 AM ET
Jenex Completes Design of TherOzap(TM) Working Prototype and Signs Service Agreement with University Health Network to Initiate Testing Against the Zika and West Nile Viruses
2017-04-07 9:16 AM ET
The Jenex Corporation Announces Shares For Debt Closing
2017-04-06 4:18 PM ET
Jenex Provides Update on TherOZap(TM) Working Prototype, and InterceptCS
2017-03-06 9:20 AM ET
Jenex Unaware of Any Material Change
2017-02-27 2:18 PM ET
Jenex Announces Proposed Debt Settlement
2017-02-13 8:00 AM ET
Jenex Provides Update on Next Generation Technology, TherOZap(TM) to Test Against the West Nile Virus and Zika Virus
2017-01-24 9:17 AM ET
2016
Jenex to Test Next Generation Technology, TherOZap(TM) Against the Zika Virus and West Nile Virus
2016-12-08 9:37 AM ET
Jenex Announces TherOZap(TM), the Company's Next Generation Thermal Therapy Insect Device and Proposed Share for Debt Settlement Terms
2016-11-18 8:39 AM ET
2016-11-03 7:00 AM ET
2016-10-18 8:00 AM ET
Jenex Issues Product Development Update
2016-09-30 8:29 AM ET
2016-05-18 9:36 AM ET
Jenex Announces Exciting Updates for InterceptCS, Fast Cold Sore Treatment for Fiscal Year 2016
2016-04-12 10:04 AM ET
Jenex Announces Appointment of New CEO and Board Changes
2016-02-11 9:00 AM ET
2015
SEC Revokes Registration of The Jenex Corporation Shares
2015-12-07 3:26 PM ET
The Jenex Corporation Announces Private Placement
2015-10-09 4:00 PM ET
2014
Jenex Announces Closing of Debt Settlement
December 11, 2014
Jenex Announces Revised Debt Settlement Terms
November 19, 2014
Jenex Announces Proposed Debt Settlement
July 9, 2014
The Jenex Corporation Update
March 5, 2014
Securities Commissions Revoke Cease Trade Orders for The Jenex Corporation
January 22, 2014
2013
Jenex Files Financial Statements
September 19, 2013
Jenex Completes Private Placement
May 21, 2013
The Jenex Corporation Provides Update on Proposed Financing
March 26, 2013